Discontinuation report GD-AZITHROMYCIN
Report ID | 62364 |
Drug Identification Number | 02274574 |
Brand name | GD-AZITHROMYCIN |
Common or Proper name | AZITHROMYCIN |
Company Name | GENMED A DIVISION OF PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | AZITHROMYCIN |
Strength(s) | 200MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL |
Packaging size | 1 Bottle (900MG/22.5ML) |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2019-12-31 |
Actual discontinuation date | |
Remaining supply date | 2019-12-31 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2018-10-19 | French | Compare |
v3 | 2018-10-19 | English | Compare |
v2 | 2018-09-25 | French | Compare |
v1 | 2018-09-25 | English | Compare |
Showing 1 to 4 of 4